testosterone enanthate · Antares Pharma Inc · NDA 209863
Xyosted (Autoinjector)
Earliest generic entry, as listed · earliest of 3 marketed strengths
4 Sep 2036
Blocked by patent: US 9950125.
Listed patents · 16 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9950125 | product, use U-2418 | 4 Sep 2036 |
| US 9744302 | product | 19 Nov 2035 |
| US 11191908 | product | 18 Oct 2035 |
| US 12629483 | product | 7 Aug 2035 |
| US 11813435 | product | 25 Feb 2035 |
| US 10238662 | product, use U-2418 | 19 Feb 2035 |
| US 10912782 | product, use U-2418 | 19 Feb 2035 |
| US 11160751 | product, use U-2418 | 7 Oct 2034 |
| US 10881798 | product | 11 Feb 2034 |
| US 10821072 | product, use U-2418 | 4 Jun 2033 |
| US 11844804 | use U-2418 | 4 Jun 2033 |
| US 10357609 | product | 21 Aug 2031 |
| US 10905827 | product | 21 Aug 2031 |
| US 11446440 | product | 21 Aug 2031 |
| US 10279131 | product | 31 Jul 2031 |
| US 11497753 | product | 19 Mar 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209863 · 001 · RLD | solution, subcutaneous | 50MG/0.5ML (50MG/0.5ML) | 4 Sep 2036 |
| 209863 · 002 · RLD | solution, subcutaneous | 75MG/0.5ML (75MG/0.5ML) | 4 Sep 2036 |
| 209863 · 003 · RLD | solution, subcutaneous | 100MG/0.5ML (100MG/0.5ML) | 4 Sep 2036 |
Expired or delisted (7)
- US 8021335 · product · 4 Oct 2026
- US 10478560 · product · 24 Jan 2026
- US 11446441 · product · 24 Jan 2026
- US 8562564 · product · 24 Jan 2026
- US 9180259 · product · 24 Jan 2026
- US 9533102 · product · 24 Jan 2026
- US 9629959 · product · 24 Jan 2026